Dynavax Technologies Stock Current Valuation
DVAX Stock | USD 11.84 0.04 0.34% |
Valuation analysis of Dynavax Technologies helps investors to measure Dynavax Technologies' intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. At this time, Dynavax Technologies' Enterprise Value Over EBITDA is fairly stable compared to the past year. Enterprise Value Multiple is likely to rise to 95.41 in 2024, whereas Enterprise Value is likely to drop slightly above 317 M in 2024. Fundamental drivers impacting Dynavax Technologies' valuation include:
Price Book 2.4907 | Enterprise Value 1.1 B | Enterprise Value Ebitda 110.0795 | Price Sales 6.6704 | Forward PE 400 |
Undervalued
Today
Please note that Dynavax Technologies' price fluctuation is very steady at this time. Calculation of the real value of Dynavax Technologies is based on 3 months time horizon. Increasing Dynavax Technologies' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Dynavax Technologies is useful when determining the fair value of the Dynavax stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Dynavax Technologies. Since Dynavax Technologies is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Dynavax Stock. However, Dynavax Technologies' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. Historical | Market 11.84 | Real 15.09 | Target 24.5 | Hype 11.77 |
The real value of Dynavax Stock, also known as its intrinsic value, is the underlying worth of Dynavax Technologies Company, which is reflected in its stock price. It is based on Dynavax Technologies' financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Dynavax Technologies' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Dynavax Technologies' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Dynavax Technologies helps investors to forecast how Dynavax stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Dynavax Technologies more accurately as focusing exclusively on Dynavax Technologies' fundamentals will not take into account other important factors: Dynavax Technologies Company Current Valuation Analysis
Dynavax Technologies' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Dynavax Technologies Current Valuation | 1.06 B |
Most of Dynavax Technologies' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Dynavax Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Dynavax Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for Dynavax Technologies is extremely important. It helps to project a fair market value of Dynavax Stock properly, considering its historical fundamentals such as Current Valuation. Since Dynavax Technologies' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Dynavax Technologies' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Dynavax Technologies' interrelated accounts and indicators.
Click cells to compare fundamentals
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition |
In accordance with the recently published financial statements, Dynavax Technologies has a Current Valuation of 1.06 B. This is 92.65% lower than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The current valuation for all United States stocks is 93.65% higher than that of the company.
Dynavax Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Dynavax Technologies' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Dynavax Technologies could also be used in its relative valuation, which is a method of valuing Dynavax Technologies by comparing valuation metrics of similar companies.Dynavax Technologies is currently under evaluation in current valuation category among related companies.
Dynavax Fundamentals
Return On Equity | -0.0106 | ||||
Return On Asset | -0.0192 | ||||
Profit Margin | (0.03) % | ||||
Operating Margin | (0.12) % | ||||
Current Valuation | 1.06 B | ||||
Shares Outstanding | 130.86 M | ||||
Shares Owned By Insiders | 0.31 % | ||||
Shares Owned By Institutions | 97.99 % | ||||
Number Of Shares Shorted | 17.97 M | ||||
Price To Earning | 6.95 X | ||||
Price To Book | 2.49 X | ||||
Price To Sales | 6.67 X | ||||
Revenue | 232.28 M | ||||
Gross Profit | 448.22 M | ||||
EBITDA | 20.98 M | ||||
Net Income | (6.39 M) | ||||
Cash And Equivalents | 518.17 M | ||||
Cash Per Share | 4.10 X | ||||
Total Debt | 256.91 M | ||||
Debt To Equity | 0.61 % | ||||
Current Ratio | 2.77 X | ||||
Book Value Per Share | 4.80 X | ||||
Cash Flow From Operations | 100.56 M | ||||
Short Ratio | 9.51 X | ||||
Earnings Per Share | (0.05) X | ||||
Target Price | 25.75 | ||||
Number Of Employees | 408 | ||||
Beta | 1.28 | ||||
Market Capitalization | 1.54 B | ||||
Total Asset | 997.1 M | ||||
Retained Earnings | (930.58 M) | ||||
Working Capital | 796.92 M | ||||
Current Asset | 199.95 M | ||||
Current Liabilities | 28.79 M | ||||
Net Asset | 997.1 M |
About Dynavax Technologies Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Dynavax Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Dynavax Technologies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Dynavax Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Dynavax Technologies Investors Sentiment
The influence of Dynavax Technologies' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Dynavax. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Dynavax Technologies' public news can be used to forecast risks associated with an investment in Dynavax. The trend in average sentiment can be used to explain how an investor holding Dynavax can time the market purely based on public headlines and social activities around Dynavax Technologies. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Dynavax Technologies' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Dynavax Technologies' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Dynavax Technologies' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Dynavax Technologies.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Dynavax Technologies in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Dynavax Technologies' short interest history, or implied volatility extrapolated from Dynavax Technologies options trading.
Pair Trading with Dynavax Technologies
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Dynavax Technologies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dynavax Technologies will appreciate offsetting losses from the drop in the long position's value.Moving together with Dynavax Stock
0.68 | EVO | Evotec SE ADR Earnings Call Tomorrow | PairCorr |
0.71 | JNJ | Johnson Johnson Aggressive Push | PairCorr |
Moving against Dynavax Stock
0.68 | CNTA | Centessa Pharmaceuticals Downward Rally | PairCorr |
0.65 | OPT | Opthea | PairCorr |
0.64 | ANIP | ANI Pharmaceuticals Financial Report 13th of May 2024 | PairCorr |
0.62 | PBH | Prestige Brand Holdings Financial Report 2nd of May 2024 | PairCorr |
0.6 | PAHC | Phibro Animal Health Financial Report 1st of May 2024 | PairCorr |
The ability to find closely correlated positions to Dynavax Technologies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Dynavax Technologies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Dynavax Technologies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Dynavax Technologies to buy it.
The correlation of Dynavax Technologies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Dynavax Technologies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Dynavax Technologies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Dynavax Technologies can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Dynavax Technologies Piotroski F Score and Dynavax Technologies Altman Z Score analysis. For more information on how to buy Dynavax Stock please use our How to Invest in Dynavax Technologies guide.Note that the Dynavax Technologies information on this page should be used as a complementary analysis to other Dynavax Technologies' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Complementary Tools for Dynavax Stock analysis
When running Dynavax Technologies' price analysis, check to measure Dynavax Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dynavax Technologies is operating at the current time. Most of Dynavax Technologies' value examination focuses on studying past and present price action to predict the probability of Dynavax Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dynavax Technologies' price. Additionally, you may evaluate how the addition of Dynavax Technologies to your portfolios can decrease your overall portfolio volatility.
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Bonds Directory Find actively traded corporate debentures issued by US companies |
Is Dynavax Technologies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dynavax Technologies. If investors know Dynavax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dynavax Technologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.77) | Earnings Share (0.05) | Revenue Per Share 1.804 | Quarterly Revenue Growth (0.70) | Return On Assets (0.02) |
The market value of Dynavax Technologies is measured differently than its book value, which is the value of Dynavax that is recorded on the company's balance sheet. Investors also form their own opinion of Dynavax Technologies' value that differs from its market value or its book value, called intrinsic value, which is Dynavax Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dynavax Technologies' market value can be influenced by many factors that don't directly affect Dynavax Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dynavax Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Dynavax Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dynavax Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.